Novozymes A/S (OTCMKTS:NVZMY) Rating Lowered to Strong Sell at Zacks Research

Novozymes A/S (OTCMKTS:NVZMYGet Free Report) was downgraded by equities research analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a research note issued on Monday,Zacks.com reports.

Separately, Rothschild & Co Redburn raised Novozymes A/S to a “strong-buy” rating in a report on Friday, March 27th. One analyst has rated the stock with a Strong Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy”.

View Our Latest Stock Report on Novozymes A/S

Novozymes A/S Stock Down 0.0%

Shares of Novozymes A/S stock opened at $62.32 on Monday. The company has a quick ratio of 0.44, a current ratio of 0.72 and a debt-to-equity ratio of 0.12. The firm has a market cap of $25.83 billion, a P/E ratio of 44.51, a P/E/G ratio of 1.17 and a beta of 0.98. Novozymes A/S has a fifty-two week low of $49.90 and a fifty-two week high of $75.99. The business has a 50-day moving average price of $58.29 and a 200 day moving average price of $61.15.

Novozymes A/S (OTCMKTS:NVZMYGet Free Report) last announced its quarterly earnings data on Tuesday, May 5th. The biotechnology company reported $0.51 earnings per share for the quarter, missing the consensus estimate of $0.82 by ($0.31). Novozymes A/S had a net margin of 13.96% and a return on equity of 6.37%. On average, sell-side analysts forecast that Novozymes A/S will post 2.42 earnings per share for the current fiscal year.

Novozymes A/S Company Profile

(Get Free Report)

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).

Further Reading

Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.